Thalassemia is a genetic blood disorder that’s easily preventable. Treatment for Thalassemia patients in Telangana involves lifelong blood transfusions, every 15-20 days, to manage the condition.

Vertex’s effort to provide fertility support services to those on government insurance programs who want to take the ...

Carlyle Group's acquisition of bluebird bio for $3 per share offers a potential but unlikely $600 million sales milestone by 2027. See why BLUE stock is a Hold.

Anemia remains a major public health concern in India, affecting women, children and pregnant mothers, leading to severe ...

The judge ruled that the primary and secondary sanctions imposed by the US against Iran have disrupted the delivery of thalassemia medications to the Iranian patients, forcing them to take low ...

Thalassemia major patients require ‘life long’ blood transfusions once every 15-20 days, and iron chelation therapy, leading to substantial financial and social costs for families and the ...

Receive FDA regulatory decision for PYRUKYND for the treatment of adult patients with non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia (PDUFA goal date is September ...

The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the ...

visited Kamala Hospital and Research Centre for Thalassemia and Sickle Cell Patients (KHRCTSCS) – a dedicated unit of the Thalassaemia and Sickle Cell Society (TSCS) in Shivrampally, Hyderabad.